LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment

LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment

Chronic inflammation is critical in the onset and progression of atherosclerosis (AS). The lipopolysaccharide (LPS) level in the circulation system is elevated in AS patients and animal models, which is correlated with the severity of AS. Inspired by the underlying mechanism that LPS could drive the...

Full description

Bibliographic Details
Main Authors: Huiwen Liu, Honglan Wang, Qiyu Li, Yiwei Wang, Ying He, Xuejing Li, Chunyan Sun, Onder Ergonul, Füsun Can, Zhiqing Pang, Bo Zhang, Yu Hu
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Lipopolysaccharide
Atherosclerosis
Polymyxin
Liposomes
Macrophages
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383523002083

Internet

http://www.sciencedirect.com/science/article/pii/S2211383523002083

Similar Items